Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Inovio COVID-19 Vaccine Trial Delayed By FDA Partial Hold

Sep 28 2020

• By Jessica Merrill

Delayed — Inovio's COVID-19 vaccine Phase II/III trial is delayed • Source: Shutterstock

Related Content

J&J COVID Vaccine: Single-Dose Format Will ‘Expedite’ Phase III Trial

Sep 23 2020

Coronavirus Update: Inovio Begins Phase I Trials of DNA Vaccine, Fast-Track Drug Dialogue Continues

Apr 07 2020

Related Companies

Inovio Pharmaceuticals, Inc.

Pfizer Inc.

Moderna, Inc.

Johnson & Johnson

Additional Topics

Coronavirus COVID-19 Vaccines Clinical Trials Research & Development BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window